← Leaderboards
Vladimir Bogdanov
Mount Sinai School Of Medicine Of Nyu
$3,457,397
Attributed
$4,281,303
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $564.2K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,281,303 · 5
By mechanism
T32$1,647,812 · 1
R01$1,387,880 · 1
R21$791,475 · 2
K01$454,136 · 1
Top collaborators
- Xiaoyang Qi4 shared
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Yale R Nemerson$1,092,105
- Steven R Levine$10,462,040
- Jacob Rand$3,335,973
- Margaret H. Baron$26,606,298
- Alison D Schecter$2,525,280
Others in their field
Top investigators on “Monocyte”
- Steven Kyle Grinspoon · Massachusetts General Hospital$29,810,751
- Pamela Susan Douglas · Duke University$25,187,001
- Gyongyi Szabo · Univ Of Massachusetts Med Sch Worcester$24,671,476
- Joan Weinberger Berman · Yeshiva University$24,336,702
- Robert L Modlin · University Of California Los Angeles$24,201,619
- Yuri Persidsky · Temple Univ Of The Commonwealth$23,010,146
Research focus
MonocyteThromboplastinProteinsCellsComplexCoagulation ProcessMacrophageIn VivoLengthTissuesHemostatic FunctionInnovationResponseRna SplicingExtracellular DomainCytoplasmic TailThrombosisPlayTransgenic MiceMalignant NeoplasmsMalignant Neoplasm Of PancreasMediatingNeoplasm MetastasisIntegrins
Grant awards (17)
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program$489,120
T32 · FY2022 · CA · contact PI
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program$461,928
T32 · FY2021 · CA · contact PI
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program$400,597
T32 · FY2020 · CA · contact PI
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program$296,167
T32 · FY2019 · CA · contact PI
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer$268,008
R01 · FY2019 · CA · contact PI
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer$276,298
R01 · FY2018 · CA · contact PI
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer$276,298
R01 · FY2017 · CA · contact PI
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer$276,298
R01 · FY2016 · CA · contact PI
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer$290,978
R01 · FY2015 · CA · contact PI
Tissue Factor splicing and pancreatic tumor progression: pilot studies$192,592
R21 · FY2013 · CA · contact PI
Tissue Factor splicing and pancreatic tumor progression: pilot studies$170,738
R21 · FY2012 · CA · contact PI
Inducible transgenes expressing EJC enriched mRNAs: a post-genomic innovation$196,250
R21 · FY2010 · HL · contact PI
Inducible transgenes expressing EJC enriched mRNAs: a post-genomic innovation$231,895
R21 · FY2009 · HL · contact PI
Expression of Alternatively Spliced Human Tissue Factor$115,615
K01 · FY2008 · DK · contact PI
Expression of Alternatively Spliced Human Tissue Factor$114,615
K01 · FY2007 · DK · contact PI
Expression of Alternatively Spliced Human Tissue Factor$113,477
K01 · FY2006 · DK · contact PI
Expression of Alternatively Spliced Human Tissue Factor$110,429
K01 · FY2005 · DK